CHARLES GROB is a professor of Psychiatry & Biobehavioral Sciences and Pediatrics and Director of the Division of Child and Adolescent Psychiatry at Harbor–UCLA Medical Center.[1] He received his two BS degrees from Oberlin College and Columbia University before receiving an MD from the State University of New York, Downstate Medical Center. Grob’s research interests include anxiety and mood disorders and also self-medication and substance abuse. The FDA approved one of his Phase 1 studies to study the psychological and physiological effects of MDMA and the hallucinogen Ayahuasca.[2][3][4][5]
